Moody's Investors Service has affirmed its "Baa1" rating to New Bedford, Mass.-based Southcoast Health, affecting $144 million of rated debt.
The rating reflects Southcoast's stable market position and operating results in fiscal year 2018, along with Moody's expectation that the system will improve operating performance throughout fiscal year 2019.
The rating outlook is stable.